GFAP and Stroke: Although there have been no previous studies examining the effects of administered EVs in oligodendrocyte formation, our results are complemented with previous data that demonstrated systemic administration of EVs significantly reduced astrocytic GFAP expression and alleviated the expression of NeuN positive neurons after stroke in mice28.